Sandoz Group AG Sponsored ADR (OTCMKTS:SDZNY - Get Free Report)'s stock price hit a new 52-week high on Monday . The company traded as high as $54.75 and last traded at $54.70, with a volume of 2168 shares trading hands. The stock had previously closed at $54.06.
Wall Street Analysts Forecast Growth
Separately, Royal Bank Of Canada upgraded Sandoz Group from a "hold" rating to a "moderate buy" rating in a report on Friday, May 2nd.
Read Our Latest Analysis on SDZNY
Sandoz Group Trading Up 0.0%
The firm has a fifty day moving average price of $50.42 and a 200 day moving average price of $45.76. The company has a debt-to-equity ratio of 0.57, a quick ratio of 0.79 and a current ratio of 1.24.
About Sandoz Group
(
Get Free Report)
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.
Featured Stories
Before you consider Sandoz Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sandoz Group wasn't on the list.
While Sandoz Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
